Lansoprazol Medical Valley

Lansoprazole, the active ingredient in Lansoprazol Medical Valley, is a proton pump inhibitor presented as an oral dosage form for oral use. It reduces gastric acid secretion and is used to treat acid‑related disorders such as gastro‑oesophageal reflux disease, peptic ulcer disease and erosive esophagitis in adults.

GNH USA supplies Lansoprazol Medical Valley as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Lansoprazole is a proton pump inhibitor indicated for several acid‑related conditions: - Gastro‑oesophageal reflux disease (GERD): provides symptomatic relief and promotes healing of the oesophageal lining. - Peptic ulcer disease: facilitates ulcer healing by decreasing gastric acidity. - Helicobacter pylori eradication: used in combination regimens to improve bacterial clearance. - Erosive esophagitis: promotes mucosal healing and reduces further damage.

Adverse reactions may occur with lansoprazole use.

Common Side Effects: - Headache: mild to moderate intensity. - Diarrhoea: usually transient. - Nausea: occasional and mild. - Abdominal pain: non‑specific discomfort. - Flatulence: increased gas. - Constipation: occasional.

Serious or Rare Side Effects: - Severe allergic reaction (anaphylaxis): swelling, rash, difficulty breathing. - Clostridioides difficile infection: persistent diarrhoea, abdominal cramping. - Low magnesium levels (hypomagnesemia): muscle cramps, irregular heartbeat. - Bone fractures: increased risk with long‑term use. - Liver enzyme elevation: jaundice, dark urine. - Acute interstitial nephritis: reduced urine output, flank pain.

Before initiating therapy, consider the following precautions: - Assess renal function: dose adjustment may be required in severe impairment. - Evaluate hepatic status: use with caution in moderate to severe liver disease. - Review concomitant medications: potential for drug‑drug interactions. - Monitor for osteoporosis: long‑term use may affect bone density. - Pregnancy and lactation: prescribe only if clearly needed after risk‑benefit assessment. - Store at ambient temperature: keep below 25 °C, in the original container, protected from moisture and light.

Lansoprazole may interact with several medicines.

Major Interactions (Avoid): - Antiretroviral protease inhibitors (e.g., atazanavir): reduced absorption, may lose efficacy. - Antifungal agents (e.g., ketoconazole, itraconazole): decreased bioavailability. - Clopidogrel: reduced antiplatelet effect, consider alternative therapy.

Moderate Interactions (Monitor Closely): - Warfarin: possible increase in INR, monitor coagulation parameters. - Methotrexate (high dose): increased serum levels, watch for toxicity. - Digoxin: may increase serum concentration, monitor cardiac status. - Diazepam: increased plasma levels, observe for enhanced sedation.